{
    "success": true,
    "response": "```json{  'leverage': true,  'derivates': true,  'swaps': true,  'inverse': true,  'replication_method': 'synthetic',  'ucits': false,  'type': 'ETP',  'complex_factors': [    'Leverage (3x inverse)',    'Inverse Strategy',    'Daily Compounding Effect',    'Derivative-based replication (implied via margin account and securities loans)',    'High Risk Profile (7/7)',    'Complex Index (inverse leveraged)',    'Explicit 'not simple' warning in KID',    'Targets sophisticated investors with advanced understanding',    'Returns determined by reference to a complex index (MiFID Art. 4(1)(18)(c))'  ],  'classification': 'complex',  'supporting_data': 'The product is an 'ETP Securities', explicitly not a UCITS, thereby removing the UCITS presumption of non-complexity. Its investment objective to provide '-3 times the value of the daily performance' of an underlying equity signifies significant leverage (3x) and an inverse strategy. Such a payoff structure necessitates the integral use of derivative instruments (or derivative-like mechanisms such as securities lending for short exposure) as part of its core strategy, not merely for efficient portfolio management. The mention of 'Margin Account' and 'securities loans' for holding underlying assets strongly implies a synthetic or derivative-based replication method, as physical replication cannot achieve a negative multiple or consistent daily leveraged returns in this manner. The product tracks the 'iSTOXX Inverse Leveraged -3x RACE Index', which is a complex index due to its leveraged and inverse nature, and likely involves complexities such as compounding effects (explicitly mentioned in the KID). The KID explicitly includes the mandatory comprehension alert: 'You are about to purchase a product that is not simple and may be difficult to understand', indicating its complex nature under MiFID II. Furthermore, the product is explicitly described as intended for 'sophisticated investors' who 'understand the risk of compounded returns and the increased risk of investment in inverse leveraged products', which contradicts the understanding level of an average retail investor with basic knowledge. It is classified as the highest risk (7 out of 7). Based on MiFID Level 1 Art. 4(1)(18)(c) and ESMA guidance (CESR/09-295, ANNEX I), instruments giving rise to a cash settlement determined by reference to such complex indices are 'ALWAYS COMPLEX'. The combination of leverage, inverse strategy, derivative-based structure, compounding effect, and explicit warnings/investor targeting conclusively classifies this ETP as complex.'}```",
    "note": "Response was not in expected JSON format"
}